This is the authors' abstract. We don't add key points for this paper.
The effect of Ara-A on collagen arthritis in rats was investigated following parenteral administration of this drug at a dose of 100mg/kg/day for 25 days starting the day before type II collagen immunization.Ara-A significantly increased the incidence and severity of collagen arthritis compaired to control rats which recieved dimethyl-sulphoxide (DMSO), vehicle used to dissolve Ara-A. While serum antibody titers to type II collagen measured by an enzyme-linked immunosorbent assay (ELISA) and delayed-type hypersensitivity (DTH) responces did not show critical increase.These data extend the previous finding that Ara-A, an antiviral chemotherapeutic agent, also stimulates murine immune response to several well defined antigens.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Arai et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: